Bitnomial launches Injective futures in US, with eyes on ETF eligibility

Image via CoinTelegraph

The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.

Read Full Report at CoinTelegraph

AI Executive Brief

/ Bitnomial introduces Injective futures in the US, marking Injective's entry into regulated derivatives markets.
/ The move supports a potential spot ETF, following a filing from Canary Capital.
/ This development could impact the cryptocurrency market and regulatory landscape.

AI-generated summary for informational purposes. Verify with original source.

Bitnomial launches Injective futures in US, with eyes on ETF eligibility

More from The Global Wire

Citizens Financial: Solid Q1 Shows No Signs Of Economic Weakness

Zonda exchange says 4.5K BTC wallet inaccessible amid withdrawal crisis

Retail traders pile into Allbirds after odd AI pivot. History shows it won't end well

Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance

General Mills announces €1.7 billion notes offering due 2056

First Horizon: A Decent Start, But Follow Through Is Key

The Global Wire — Live Front Page